Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

Venture capital last summer began finally reckoning with its lack of Black investors, as part of the country's broader conversation on racial inequities.

The big picture: The relative handful of existing Black venture capitalists were deluged with recruiting calls from brand-name firms, both to poach and to solicit introductions. But many felt there was a pipeline problem.

  • Not a lack of qualified Black candidates, but too few Black professionals in traditional feeder industries (tech, banking, etc.) who viewed VC as a viable career path, or who had venture capitalists in their personal networks.

A group called BLCK VC, in partnership with Anthemis and Lerer Hippeau, responded by creating what it called the NYC Path Program, described as an "on-road for Black professionals to discover jobs in venture capital."

  • More than 300 applications came in, with 21 selected for the debut cohort.
  • The eight-week program launched last October. On Thursday nights, a VC firm partner like Rebecca Kaden of USV or Nikhil Sachdev of Insight Partners would gave an overview of a different topic, such as early-stage due diligence vs. later-stage due diligence or post-investment responsibilities. Then, on Fridays, participants split into smaller groups with their mentor, typically a VC firm principal or senior associate.
  • Jillian Williams, a principal with Anthemis, says that many participants were surprised by how early-stage investing is much more qualitative than quantitative.
  • The program then created a "look book" to show firms that came calling for candidates, as the majority of participants came away with interest in the industry (some, of course, decided it wasn't for them).

What next: BLCK VC is in the process of determining how the program will evolve.

  • Expectations are to host the program twice per year in New York, once in the spring and once in the fall, with broader geographic roll-0ut still being discussed.
  • Cohorts will be kept small so that individuals can more effectively engage with VCs and each other. She adds that

The bottom line: The first step toward rectifying a problem is recognizing that there is a problem. Much of venture capital seems to have done so. The second step is launching and encouraging efforts like the Path Program, so that the industry doesn't backslide, once the socio-political spotlight dims.

Go deeper

Black residents in Tampa Bay face big COVID vaccine disparities

James Bryant, left, and his wife Eunice register to receive the COVID-19 vaccine at St. Johns Missionary Baptist Church in Tampa earlier this month. Photo: Octavio Jones/Getty Images

Tampa Bay's vaccination rate for Black residents is startlingly low.

By the numbers: Of the 54,725 people who have received the COVID-19 vaccine in Sarasota-Manatee, only 812 are Black.

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities in Syria linked to Iranian-backed militia groups was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

5 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.